Translumina SPARX Clinical Trial: 1,380-Patient DCB Study
Translumina SPARX clinical trial: 1,380 patients, 10 countries, drug-coated balloons versus stents. The trial has just started, so no results yet.
Translumina SPARX clinical trial: 1,380 patients, 10 countries, drug-coated balloons versus stents. The trial has just started, so no results yet.